Adcock Ingram Limited
Records under this name other than patents Adcock Ingram Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Adcock Ingram Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,122,577 | Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the treatment and diagnosis of disease Term ended Term ended Jun 15, 2020 · USPTO record | Term ended | Term ended Jun 15, 2020 | USPTO record |
| US 6,433,013 | Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease Term ended Term ended Mar 13, 2018 · USPTO record | Term ended | Term ended Mar 13, 2018 | USPTO record |
| US 6,171,830 | Method for the isolation and purification of lipid cell-wall components Term ended Term ended Nov 6, 2017 · USPTO record | Term ended | Term ended Nov 6, 2017 | USPTO record |
| US 6,124,105 | Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein Term ended Term ended Feb 11, 2017 · USPTO record | Term ended | Term ended Feb 11, 2017 | USPTO record |
| US 6,458,367 | Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein Term ended Term ended Apr 13, 2015 · USPTO record | Term ended | Term ended Apr 13, 2015 | USPTO record |
| US 5,385,671 | Magnesium hydroxide recovery Term ended Term ended no later than Jan 31, 2015 · Low confidence | Term ended | Term ended no later than Jan 31, 2015 | Low confidence |
| US 5,763,442 | Anti-parasitic activity Formerly held Term ended Term ended no later than Jun 9, 2018 · Low confidence | Term ended | Term ended no later than Jun 9, 2018 | Low confidence |
| US 5,763,443 | MDR resistance treatment and novel pharmaceutically active riminophenazines Formerly held Term ended Term ended no later than Jun 9, 2018 · Low confidence | Term ended | Term ended no later than Jun 9, 2018 | Low confidence |